How can the personal discovery process evolve personalized medicine? An interview with Laura Towart

1Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Laura is the Founder and CEO of My Personal Therapeutics, a London-based digital health company offering the most advanced personalized cancer therapeutics. She is also the Founder and former CEO of Celmatix, a leader in diagnostics and predictive analytics for female infertility and women's health. She is a graduate of the Weill Cornell Graduate School of Medical Sciences and Memorial Sloan Kettering Cancer Center's Doctoral program and received a Certificate in Bioinformatics. She holds a BS/BA in Biology/English from The George Washington University. Besides being passionate about personalized medicine, she enjoys exploring the world with her children Julian, Valentina and Delphine.

Cite

CITATION STYLE

APA

Towart, L. A. (2019). How can the personal discovery process evolve personalized medicine? An interview with Laura Towart. Personalized Medicine. Future Medicine Ltd. https://doi.org/10.2217/pme-2019-0087

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free